Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial.
about
Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restrictionDo fatty acids affect fetal programming?Auditory- and visual-evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy.Does prenatal micronutrient supplementation improve children's mental development? A systematic reviewDocosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.Effects of n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on neurodevelopment and visual function in children: a systematic review of randomized controlled trials.Long-term effects of prenatal omega-3 fatty acid intake on visual function in school-age children.Long-chain n-3 PUFA: plant v. marine sources.Docosahexaenoic acid supplementation in pregnancy and lactation.Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age.Mercury levels in an urban pregnant population in Durham County, North CarolinaMaternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring.The effects of maternal supplementation of polyunsaturated Fatty acids on visual, neurobehavioural, and developmental outcomes of the child: a systematic review of the randomized trials.Effect of placental function on fatty acid requirements during pregnancy.Omega-3 fatty acid supplementation during pregnancy: for mother, baby, or neither?Prenatal and early postnatal fatty acid status and neurodevelopmental outcome.The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations.Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid.Maternal DHA levels and toddler free-play attentionEarly determinants of development: a lipid perspective.Prenatal DHA supplementation and infant attention.Omega 3 fatty acids, gestation and pregnancy outcomes.Omega 3 fatty acids on child growth, visual acuity and neurodevelopment.A multidisciplinary reconstruction of Palaeolithic nutrition that holds promise for the prevention and treatment of diseases of civilisation.Pregnancy and Infants' Outcome: Nutritional and Metabolic Implications.Treating phenylketonuria: a single centre experience.A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria.Mumomega® and central nervous system development - Scientific substantiation of a health claim related to Mumomega® and central nervous system development pursuant to Article 14 of Regulation (EC) No 1924/2006 - Scientific Opinion of the Panel on ...DHA and support of the visual development of the unborn child and breastfed infant - Scientific substantiation of a health claim related to DHA and support of the visual development of the unborn child and breastfed infant pursuant to Article 14 o...Scientific Opinion on health benefits of seafood (fish and shellfish) consumption in relation to health risks associated with exposure to methylmercuryA Third-Generation Lipid Emulsion that Contains n-3 Long-Chain PUFAs Preserves Retinal Function in Parenterally Fed Neonatal Piglets.Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids.Relationship between umbilical cord essential fatty acid content and the quality of general movements of healthy term infants at 3 months.
P2860
Q24245267-816D3322-10DC-40C4-B8D0-A551D086AE9FQ28071682-66931CEA-5A56-4D4C-978F-4B8E221A5613Q30451577-C3D85CD5-985C-412A-BD47-09A425432598Q33811354-EFA027EC-E5F4-4A21-9B0F-11C5913B2607Q33850028-23DDC40F-DB2D-46E5-A7DF-1D5A4956BC0FQ33877149-82A0D0C8-BCDA-4611-92F2-51322525E94AQ34355652-BAD122AC-8ABA-4B25-B7A3-B27D9DFE3F13Q34564531-CCFCEED2-0A06-4797-A86B-CB0CFBA3F654Q34602556-864773FF-0D75-4AA1-8342-1732A31248C1Q34793109-D7B3C2FA-7354-4ACC-A4A9-210013246104Q34874496-954F95AC-5D3E-4A15-80E1-F68FF38CF476Q34899136-97B5BBD8-39F7-4EFA-BC17-C8A20688DD1FQ35725432-E91E6237-4B20-46C4-9B65-F14B3E90E2E7Q35842130-3E1DC701-B651-4A88-8681-38D640889D12Q35941897-7BC35456-3AEC-40C5-B10B-AE5912B0FB2AQ36736381-BFB3B714-9A98-4344-AB42-A5447D32C7E6Q37053819-0350FA69-5E9E-4C57-AD91-066C819F3866Q37062363-B7E39CB5-779E-4CF4-B5BD-70EEB064A9EDQ37117242-925AD22B-0AE7-44FA-94B8-1048D1768148Q37179156-CDDAF73A-34DF-4117-9F6B-822119726030Q37511956-F431DE98-901B-4174-B109-A241BA4F8168Q38010564-474AD9F2-3A32-401F-A30C-0E7F4CFCE60DQ38010565-A224BE3D-1188-429E-86BE-55A686D412C0Q38034841-E1CA1AC3-CB45-4885-9C91-0482E8234880Q38195866-C9222F22-2C5E-4FBE-AAB6-00EACD7BA232Q46885006-AA757D8B-E593-4F36-B25C-4BBBB22B4529Q46948399-BB6896AE-F22A-46D5-BAAF-F4ED53628D2AQ47146106-1BBA3F35-F80C-47F1-8306-1BBE9F08032CQ47146477-94F5FE83-272E-4F6B-890E-43162D0B3488Q47154740-01C0D704-7EAC-4343-B3FA-6F40B49A8CC6Q51737029-F4628FB6-223F-4981-B028-E5BF047DC8E2Q51914557-74BAF179-D287-4739-B1C1-DDFFAD6C1161Q53928891-3D4BB932-8534-4A7A-BB78-1836489C5772
P2860
Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@ast
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@en
type
label
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@ast
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@en
prefLabel
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@ast
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@en
P2093
P2860
P356
P1476
Maternal docosahexaenoic acid ...... prospective, randomised trial.
@en
P2093
Malcolm CA
McCulloch DL
Montgomery C
Shepherd A
P2860
P304
P356
10.1136/FN.88.5.F383
P577
2003-09-01T00:00:00Z